[Adyston delayed-action capsules. Treatment of hypotonic blood circulation disorders with Adyston delayed-action capsules. Results of a field study].
D015078:2-Hydroxyphenethylamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002214:Capsules; D002648:Child; D003692:Delayed-Action Preparations; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007022:Hypotension / Q000188:drug therapy*; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use*
D002214:Capsules; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D010627:Phenethylamines; D013566:Sympathomimetics; C016209:norfenefrine, pholedrine drug combination; D008694:Methamphetamine; D015078:2-Hydroxyphenethylamine
Adyston Retardkapseln. Die Behandlung der hypotonen Kreislaufregulationsstörungen mit Adyston Retardkapseln. Ergebnisse einer Feldstudie.